Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysis

BACKGROUND: Human epidermal growth factor receptor 2 (HER2) overexpressing malignancies, including breast and gastro-esophageal, are associated with a poor prognosis. The cardiotoxicity of trastuzumab, a HER2-targeting monoclonal antibody, is well established. However, the cardiotoxic effect of pert...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhussein, Muhammad Mustafa, Mokbel, Abir, Cosman, Tammy, Aghel, Nazanin, Yang, Eric H., Mukherjee, Som D., Dent, Susan, Ellis, Peter M., Dhesy-Thind, Sukhbinder, Leong, Darryl P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Systematic Review/Meta-analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640623/
https://www.ncbi.nlm.nih.gov/pubmed/34901806
http://dx.doi.org/10.1016/j.cjco.2021.06.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640623/
https://www.ncbi.nlm.nih.gov/pubmed/34901806
http://dx.doi.org/10.1016/j.cjco.2021.06.019

Ejemplares similares